A phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with advanced melanoma.

Saba Shaikh,Yan Zang,Janel Hanmer,Hong Wang,Yan Lin,Diwakar Davar,Hassane M. Zarour,John M. Kirkwood,Yana G. Najjar

A phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with advanced melanoma.

2021

Saba Shaikh
Yan Zang
Janel Hanmer
Hong Wang
Yan Lin
Diwakar Davar
Hassane M. Zarour
John M. Kirkwood
Yana G. Najjar

e21506Background: Management of patients (pts) with advanced melanoma includes anti-PD1 with or without anti-CTLA4, and for pts with a BRAF mutation, the additional option of targeted therapy. Prec...

Keywords:

Medicine
Targeted therapy
Internal medicine
Vemurafenib
Cobimetinib
in patient
advanced melanoma
Pembrolizumab
Oncology
Mutation (genetic algorithm)

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations